AMIE FANNIN: Open Payments
NPI 1467635391 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,095 in 162 payments from 17 companies in 2025. Trend: 2023 $87 · 2024 $2,258 · 2025 $3,095
Food & beverage: $3,095
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $845 |
| Janssen Biotech, Inc. | 19 | $480 |
| Ardelyx, Inc. | 25 | $388 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $262 |
| Regeneron Healthcare Solutions, Inc. | 11 | $232 |
| Novo Nordisk Inc | 10 | $224 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $201 |
| Celltrion USA Inc. | 5 | $112 |
| Madrigal Pharmaceuticals | 6 | $99 |
| GENZYME CORPORATION | 3 | $68 |
Products named: TREMFYA, RINVOQ, IBSRELA, DUPIXENT, ENTYVIO, Wegovy, CREON, XIFAXAN.
Industry payments across KY — which companies pay providers there.
